GIP
CLBT icon

General Industrial Partners’s Cellebrite CLBT Stock Holding History

General Industrial Partners’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-533,697
Closed -$4.28M – 6
2021
Q4 		$4.28M Buy
+533,697
New +$5.03M 2.07% 6

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
IP
Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CC
Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MCM
Makena Capital Management Menlo Park, California $866M AUM 17.79% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

General Industrial Partners's CLBT Position: Q1 2022 in Review

General Industrial Partners sold out of Cellebrite (CLBT) in Q1 2022, closing a stake of 533,697 shares — an estimated $4.28M sold.

General Industrial Partners first reported a position in CLBT in Q4 2021 and held it in 1 quarter. The position peaked at $4.28M in Q4 2021. 49 funds tracked by Wall St. Rank hold CLBT as of Q1 2022.

  • General Industrial Partners reported no remaining Cellebrite position as of Q1 2022 after selling out during the quarter.
  • General Industrial Partners sold 533,697 Cellebrite shares in Q1 2022, an estimated $4.28M.
  • General Industrial Partners first reported a position in Cellebrite in Q4 2021 and held it in 1 quarter.
  • General Industrial Partners's Cellebrite position peaked at $4.28M in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Cellebrite as of Q1 2022.

Based on General Industrial Partners's 13F filing for Q1 2022, filed 16 May 2022.